LEVEL 4 B02BD02Copy

Δραστικές

Φάρμακα

• ADVATECopy
• AFSTYLACopy
• ELOCTACopy
• FANHDICopy
• HAEMOCTINCopy
• KOGENATECopy
• KOVALTRYCopy
• REFACTOCopy

• DRUGBANK - Antihemophilic Factor
• indication:

  For the treatment of hemophilia A, von Willebrand diseae and Factor XIII deficiency

• pharmacology:

• mechanism:

  Antihemophilic factor (AHF) is a protein found in normal plasma which is necessary for clot formation. The administration of AHF provides an increase in plasma levels of AHF and can temporarily correct the coagulation defect of patients with hemophilia A (classical hemophilia).

• toxicity:

• absorprion:

• halflife:

  8.4-19.3 hrs

• roouteelimination:

• volumedistribution:

• clearance:

  * 4.1 mL/h•kg [Previously treated pediatric patients]